On the involvement of the caudate-putamen, globus pallidus and substantia nigra with neuroleptic and cholinergic modification of locomotor activity.
D000818:Animals; D001115:Arecoline / Q000494:pharmacology; D001479:Basal Ganglia / Q000502:physiology*; D002421:Caudate Nucleus / Q000502:physiology; D003864:Depression, Chemical; D005917:Globus Pallidus / Q000502:physiology; D006220:Haloperidol / Q000494:pharmacology*; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D009539:Nicotinic Acids / Q000494:pharmacology*; D051381:Rats; D013378:Substantia Nigra / Q000502:physiology*
D009539:Nicotinic Acids; D001115:Arecoline; D006220:Haloperidol